CN Patent

CN103896833B — 索拉非尼对甲苯磺酸盐溶剂化物多晶型物及其制法和用途

Assigned to Dafeng Acebright Pharmaceuticals Co ltd · Expires 2016-12-28 · 9y expired

What this patent protects

本发明涉及索拉非尼对甲苯磺酸盐溶剂化物多晶型物及其制法和用途。具体地，本发明公开了索拉非尼对甲苯磺酸盐NMP溶剂化物多晶型物(NMP‑1，NMP‑2和NMP‑3)及其制备方法。通过本发明所述制备方法制得的索拉非尼对甲苯磺酸盐N‑甲基吡咯烷酮溶剂化物晶型，具有热稳定性好，储存稳定等优点。

USPTO Abstract

本发明涉及索拉非尼对甲苯磺酸盐溶剂化物多晶型物及其制法和用途。具体地，本发明公开了索拉非尼对甲苯磺酸盐NMP溶剂化物多晶型物(NMP‑1，NMP‑2和NMP‑3)及其制备方法。通过本发明所述制备方法制得的索拉非尼对甲苯磺酸盐N‑甲基吡咯烷酮溶剂化物晶型，具有热稳定性好，储存稳定等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN103896833B
Jurisdiction
CN
Classification
—
Expires
2016-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Dafeng Acebright Pharmaceuticals Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.